BDNF and Alzheimer disease: OS roles in AD neuropathology lead to decreased BDNF levels by suppressing and reducing cAMP response element-binding (CREB) expression and its phosphorylated-CREB (pCREB) content, increased nuclear factor-kappa B (NF-kB) DNA-binding activity, and energy depletion (Figure 1)17,18.